These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 6185698

  • 21. Clinical behaviour of prostatic specific antigen and prostatic acid phosphatase: a comparative study.
    Morote Robles J, Ruibal Morell A, De Torres Mateos JA, Soler Roselló A.
    Int J Biol Markers; 1989; 4(2):87-94. PubMed ID: 2475553
    [Abstract] [Full Text] [Related]

  • 22. Counterimmunoelectrophoretic studies of serum prostatic acid phosphatase.
    Romas NA, Hsu KC, Ng PY, Pitts M, Tomashefsky P, Tannenbaum M.
    Prostate; 1980; 1(4):451-6. PubMed ID: 6169076
    [Abstract] [Full Text] [Related]

  • 23. Comparison of countercurrent immunoelectrophoretic assay with commercial radioimmunoassay kits for measuring prostatic acid phosphatase.
    Wright GL, Schellhammer PF, Brassil DN, Sieg SM, Leffell MS.
    Clin Chem; 1981 Oct; 27(10):1747-52. PubMed ID: 6169470
    [Abstract] [Full Text] [Related]

  • 24. Bone marrow acid phosphatase by radioimmunoassay.
    Belville WD, Cox HD, Mahan DE, Olmert JP, Mittemeyer BT, Bruce AW.
    Cancer; 1978 Jun; 41(6):2286-91. PubMed ID: 77719
    [Abstract] [Full Text] [Related]

  • 25. [Determination of prostatic specific antigen and prostatic acid phosphatase as tumor markers of cancer of the prostate].
    Morote Robles J, de Torres Mateos JA.
    Arch Esp Urol; 1989 Jun; 42 Suppl 2():124-30. PubMed ID: 2484148
    [Abstract] [Full Text] [Related]

  • 26. Radioimmunoassay (RIA) for prostatic acid phosphatase in patients with prostatic carcinoma.
    Debruyne FM, van Munster PJ, van Groeninghen JC, Kirkels WJ.
    Urol Res; 1984 Jun; 12(5):233-7. PubMed ID: 6083652
    [Abstract] [Full Text] [Related]

  • 27. Radioimmunoassay of prostatic acid phosphatase: validation and clinical application.
    Franchimont P, Bouffioux C, Reuter A, Rigo-Betz C, Vrindts-Gevaert Y, Jaspar JM, Lecomte-Yerna MJ.
    Int J Cancer; 1983 Feb 15; 31(2):149-55. PubMed ID: 6826245
    [No Abstract] [Full Text] [Related]

  • 28. [Detection of prostatic acid phosphatase by an immunochemical method. 4. Comparison with radioimmunoassay].
    Sakai S, Kato N, Ishiyama S, Fujimoto Y, Deguchi T, Muranaka K, Setsuda O, Kuriyama M, Kawada Y, Nishiura T.
    Nihon Hinyokika Gakkai Zasshi; 1983 Jun 15; 74(6):945-55. PubMed ID: 6197550
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Lack of value of radioimmunoassay for prostatic acid phosphatase as a screening test for prostatic cancer in patients with obstructive prostatic hyperplasia.
    Fleischmann J, Catalona WJ, Fair WR, Heston WD, Menon M.
    J Urol; 1983 Feb 15; 129(2):312-4. PubMed ID: 6187945
    [Abstract] [Full Text] [Related]

  • 31. Rapid, fully automated radioimmunoassay of prostatic acid phosphatase in serum.
    Dass S, Bowen NL, Bagshawe KD.
    Clin Chem; 1980 Oct 15; 26(11):1583-7. PubMed ID: 6158384
    [Abstract] [Full Text] [Related]

  • 32. The significance of prostatic acid phosphatase in adenocarcinoma of the prostate.
    Bruce AW, Mahan DE, Sullivan LD, Goldenberg L.
    J Urol; 1981 Mar 15; 125(3):357-60. PubMed ID: 6162968
    [Abstract] [Full Text] [Related]

  • 33. Prostatic acid phosphatase and prostatic cancer.
    Foti AG, Cooper JF, Herschman H.
    Recent Results Cancer Res; 1979 Mar 15; 67():45-9. PubMed ID: 88065
    [No Abstract] [Full Text] [Related]

  • 34. Enzyme immunoassay of prostatic acid phosphatase after prostatic examination. Correlation with prostate size and immunopathology.
    el-Shirbiny AM, Shridhar P, al Adnani MS, Suresh LK.
    Urology; 1988 Nov 15; 32(5):469-73. PubMed ID: 2460989
    [Abstract] [Full Text] [Related]

  • 35. Screening for carcinoma of the prostate. Rectal examination, and enzymatic and radioimmunologic measurements of serum acid phosphatase compared.
    Vihko P, Kontturi M, Lukkarinen O, Ervasti J, Vihko R.
    Cancer; 1985 Jul 01; 56(1):173-7. PubMed ID: 4005787
    [Abstract] [Full Text] [Related]

  • 36. Perspectives on serum acid phosphatase in prostatic disease. An evaluation of two methods.
    Dedorson S, Fritjofsson A, Norlen BJ, Ronquist G.
    Ups J Med Sci; 1983 Jul 01; 88(2):127-39. PubMed ID: 6649190
    [Abstract] [Full Text] [Related]

  • 37. [Tumor markers of prostate cancer--evaluation of serum PAP and PA].
    Miki M.
    Gan No Rinsho; 1985 May 01; 31(6 Suppl):664-9. PubMed ID: 2411965
    [Abstract] [Full Text] [Related]

  • 38. Correlation between serum values of prostatic acid phosphatase and morphometric analysis in the cytologic diagnosis of prostatic carcinoma.
    Clar-Blanch F, Morell-Quadreny L, Fenollosa-Entrena B, Chuan-Nuez P, Gil-Salom M, Carretero-Gonzalez P, Llombart-Bosch A.
    Eur Urol; 1992 May 01; 21 Suppl 1():75-8. PubMed ID: 1385135
    [Abstract] [Full Text] [Related]

  • 39. [Studies on the measurement of serum prostatic acid phosphatase with RIA-Quant PAP test kit (author's transl)].
    Kawamura J, Yoshida O, Kousaka T, Yoshii M, Morita R, Torizuka K.
    Kaku Igaku; 1982 Mar 01; 19(2):313-22. PubMed ID: 7109329
    [No Abstract] [Full Text] [Related]

  • 40. [Serum prostatic acid phosphatase].
    Chen M, Gai M, Fishelovitz J, Hegesh E.
    Harefuah; 1983 May 01; 104(9):378-80. PubMed ID: 6674043
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.